Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy

Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy

Objectives: Immune checkpoint inhibitors (ICIs) have led to a paradigm shift in non-small cell lung cancer (NSCLC) treatment. We investigated absolute eosinophil count (AEC) as a predictor of clinical outcomes and toxicity in NSCLC patients receiving ICIs. Materials and Methods: AEC was retrospectiv...

Full description

Bibliographic Details
Main Authors: Enrico Caliman, Sara Fancelli, Carlotta Ottanelli, Francesca Mazzoni, Luca Paglialunga, Daniele Lavacchi, Marta Rita Gatta Michelet, Elisa Giommoni, Brunella Napolitano, Federico Scolari, Luca Voltolini, Camilla Eva Comin, Serena Pillozzi, Lorenzo Antonuzzo
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Non-small cell lung cancer
Immunotherapy
Eosinophils
Absolute eosinophil count
Biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000934

Similar Items

Similar Items